Tau-targeting therapies for Alzheimer disease
EE Congdon, EM Sigurdsson - Nature Reviews Neurology, 2018 - nature.com
Alzheimer disease (AD) is the most common form of dementia. Pathologically, AD is
characterized by amyloid plaques and neurofibrillary tangles in the brain, with associated …
characterized by amyloid plaques and neurofibrillary tangles in the brain, with associated …
[HTML][HTML] Tau PET imaging in neurodegenerative tauopathies—still a challenge
The accumulation of pathological misfolded tau is a feature common to a collective of
neurodegenerative disorders known as tauopathies, of which Alzheimer's disease (AD) is …
neurodegenerative disorders known as tauopathies, of which Alzheimer's disease (AD) is …
[HTML][HTML] Novel therapeutic approaches for Alzheimer's disease: an updated review
Alzheimer's disease (AD) is a progressive neurodegenerative disease and accounts for
most cases of dementia. The prevalence of AD has increased in the current rapidly aging …
most cases of dementia. The prevalence of AD has increased in the current rapidly aging …
[HTML][HTML] Status and challenges of plant-anticancer compounds in cancer treatment
Nowadays, cancer is one of the deadliest diseases in the world, which has been estimated
to cause 9.9 million deaths in 2020. Conventional treatments for cancer commonly involve …
to cause 9.9 million deaths in 2020. Conventional treatments for cancer commonly involve …
Cdk5 disruption attenuates tumor PD-L1 expression and promotes antitumor immunity
RD Dorand, J Nthale, JT Myers, DS Barkauskas, S Avril… - Science, 2016 - science.org
Cancers often evade immune surveillance by adopting peripheral tissue–tolerance
mechanisms, such as the expression of programmed cell death ligand 1 (PD-L1), the …
mechanisms, such as the expression of programmed cell death ligand 1 (PD-L1), the …
[HTML][HTML] Medical treatment of Cushing's disease: an overview of the current and recent clinical trials
R Pivonello, R Ferrigno, MC De Martino… - Frontiers in …, 2020 - frontiersin.org
Cushing's disease (CD) is a serious endocrine disorder characterized by chronic
hypercortisolism, or Cushing's syndrome (CS), caused by a corticotroph pituitary tumor …
hypercortisolism, or Cushing's syndrome (CS), caused by a corticotroph pituitary tumor …
Therapeutic targeting of transcriptional cyclin-dependent kinases
MD Galbraith, H Bender, JM Espinosa - Transcription, 2019 - Taylor & Francis
The fact that many cancer types display transcriptional addiction driven by dysregulation of
oncogenic enhancers and transcription factors has led to increased interest in a group of …
oncogenic enhancers and transcription factors has led to increased interest in a group of …
Targeting CDK9 with selective inhibitors or degraders in tumor therapy: an overview of recent developments
L Xiao, Y Liu, H Chen, L Shen - Cancer Biology & Therapy, 2023 - Taylor & Francis
As a catalytic subunit of the positive transcription elongation factor b (P-TEFb), cyclin-
dependent kinase 9 (CDK9) has been demonstrated to contribute to carcinogenesis. This …
dependent kinase 9 (CDK9) has been demonstrated to contribute to carcinogenesis. This …
Analyzing the scaffold diversity of cyclin‐dependent kinase inhibitors and revisiting the clinical and preclinical pipeline
D Bhurta, SB Bharate - Medicinal Research Reviews, 2022 - Wiley Online Library
Kinases have gained an important place in the list of vital therapeutic targets because of
their overwhelming clinical success in the last two decades. Among various clinically …
their overwhelming clinical success in the last two decades. Among various clinically …
[HTML][HTML] Cheminformatics tools for analyzing and designing optimized small-molecule collections and libraries
Libraries of well-annotated small molecules have many uses in chemical genetics, drug
discovery, and therapeutic repurposing. Multiple libraries are available, but few data-driven …
discovery, and therapeutic repurposing. Multiple libraries are available, but few data-driven …